childhood epilepsy

News

Marcio Souza, Praxis' president and chief executive

Praxis soars on rare childhood epilepsy trial data

Praxis looks like it could be filing for approval of two products next year, after its childhood epilepsy drug delivered a win in a pivotal trial.

News

Case builds for Biogen, Stoke's Dravet syndrome drug

Hopes have risen for a new treatment for severe childhood epilepsy Dravet syndrome, on the back of new data for Biogen and Stoke's zorevunersen.

Views & Analysis

Taking on the challenge of childhood epilepsy

Japan’s Eisai has a long-term commitment to treating epilepsy, with a series of therapies already on the market - but with many different forms of the disease, requiring different therapeutic appro

Praxis soars on rare childhood epilepsy trial data

Case builds for Biogen, Stoke's Dravet syndrome drug

Taking on the challenge of childhood epilepsy

Iambic prices its IPO, seeking to raise up to $160m

Discover a new era of healthcare panel engagement: Grounded ...

Editor's Picks